Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

[1]  Andrew E. Williams,et al.  Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative , 2021, JAMA network open.

[2]  M. Ar Gouilh,et al.  Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial , 2021, EClinicalMedicine.

[3]  G. McComsey,et al.  Clinical Features and Outcomes of Coronavirus Disease 2019 Among People With Human Immunodeficiency Virus in the United States: A Multicenter Study From a Large Global Health Research Network (TriNetX) , 2021, Open forum infectious diseases.

[4]  Á. Soriano,et al.  Overview of SARS-CoV-2 infection in adults living with HIV , 2021, The Lancet HIV.

[5]  David R. Holtgrave,et al.  COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State , 2021, JAMA network open.

[6]  L. Waters,et al.  COVID-19 death in people with HIV: interpret cautiously , 2020, The Lancet HIV.

[7]  K. Bhaskaran,et al.  HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform , 2020, The Lancet HIV.

[8]  C. Sabin,et al.  Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[9]  Philip R. O. Payne,et al.  The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment , 2020, J. Am. Medical Informatics Assoc..

[10]  Y. Hadi,et al.  Characteristics and outcomes of COVID-19 in patients with HIV: a multi-center research network study. , 2020, AIDS.

[11]  D. Jannat-Khah,et al.  COVID-19 in Hospitalized Adults With HIV , 2020, Open forum infectious diseases.

[12]  M. Peluso,et al.  Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus , 2020, The Journal of Infectious Diseases.

[13]  Jessica K De Freitas,et al.  Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[14]  J. Babik,et al.  COVID-19 in Immunocompromised Hosts: What We Know So Far , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  M. Hernán,et al.  Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy , 2020, Annals of Internal Medicine.

[16]  Haipeng Zhang,et al.  CD4+T, CD8+T counts and severe COVID-19: A meta-analysis , 2020, Journal of Infection.

[17]  Mike Clarke,et al.  A minimal common outcome measure set for COVID-19 clinical research , 2020, The Lancet Infectious Diseases.

[18]  F. Bongomin,et al.  Prevalence, clinical characteristics and treatment outcomes of HIV and SARS-CoV-2 co-infection: a systematic review and meta-analysis , 2020 .

[19]  Simon A. Jones,et al.  Outcomes Among HIV-Positive Patients Hospitalized With COVID-19 , 2020, Journal of acquired immune deficiency syndromes.

[20]  R. Trimble.  COVID-19 Dashboard , 2020 .

[21]  Joseph E. Lucas,et al.  Development and validation of an electronic medical record (EMR)-based computed phenotype of HIV-1 infection , 2018, J. Am. Medical Informatics Assoc..

[22]  Vivienne J. Zhu,et al.  Feasibility and utility of applications of the common data model to multiple, disparate observational health databases , 2015, J. Am. Medical Informatics Assoc..

[23]  Bing Li,et al.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.